← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 20, 2019Last known activity
Feb 8, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Recent trials (6)
- NCT05245734CollaboratorPhase 3Feb 8, 2022
- NCT04797936Reponsible party - principal investigatorPhase 4May 1, 2020
- NCT04797936Overall official - principal investigatorPhase 4May 1, 2020
- NCT04797936Lead sponsorPhase 4May 1, 2020
- NCT04537819Lead sponsorN/AMar 20, 2019
- NCT04537819Overall official - principal investigatorN/AMar 20, 2019
Details
- Last known activity
- Feb 8, 2022